ATRYS HEALTH ACQUIRES REAL LIFE DATA, CONSOLIDATING ITS POSITION AS A BENCHMARK IN THE PROVISION OF MEDICAL SERVICES
24/07/2019
Diego Gutiérrez
ATRYS HEALTH ACQUIRES REAL LIFE DATA, CONSOLIDATING ITS POSITION AS A BENCHMARK IN THE PROVISION OF MEDICAL SERVICES

Real Life Data, the Spanish leader in Smart/Big Data in the healthcare sector in Spain, has been acquired by Atrys Health, a biomedical company. This transaction highlights the importance of a trend that is revolutionising the world of healthcare, the use of Big Data and Artificial Intelligence.

Real Life Data is a company located in Madrid specialising in Big Data to gain in-depth knowledge of the evolution and extent of the pathologies of its clients.. It develops highly advanced projects in health research through the use of data for the pharmaceutical and health sector.

Real Life Data and Atrys Health merger

Atrys Healthwhich is listed on the MAB, is a company dedicated to the provision of diagnostic services and medical treatments of excellence. The aim is to facilitate individualised therapy for patients, as well as the development of new therapeutic modalities and diagnostic tools.

This operation represents an important step for Atrys, consolidating its position as a benchmark in the provision of medical services by adding a new dimension to the services it currently provides. In particular, it will be able to strengthen its work in the field of predictive medicine, reinforcing its R&D area and developing knowledge on the evolution and extent of pathologies.

Big Data and the Artificial Intelligence are gaining a lot of traction in the health sector.

The following are some of the most relevant operations that follow this trend:

APTAR PHARMA BUYS GATEWAY ANALYTICAL

Aptar Pharma is a US company that through the use of innovative technologies has managed to reinvent itself in its traditional drug delivery business.. As part of its strategy to expand its portfolio of services, it has acquired Gateway Analytical.

Aptar expects the purchase of this analytical services laboratory that provides chemical analysis and material analysis solutions to add value and enhance its analytical and data management capabilities.

WAYSTAR ACQUIRES DIGITIZE.AI

Waystar is a company whose objective is to helping healthcare organisations to simplify and unify their revenue cycle. Aware of the annual cost of 30M$ The aim is to automate and simplify these processes, in order to reduce the costs to the industry of manual financial data entry errors.

Digitize.AI uses Artificial Intelligence in the insurance industry to improve decision making. Using an algorithm, it automates and simplifies the value chain in this sector. In this way, Waystar continues with its growth plan related to cost optimisation.

Lastest news

Amazon’s strategic acquisitions in 2024: A comprehensive analysis

En 2024, Amazon dio grandes pasos en la expansión de sus capacidades y su influencia en el mercado a través de una serie de adquisiciones de alto perfil. Estas adquisiciones reflejan el compromiso continuo de Amazon con la innovación, la diversificación y el dominio...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

Request for information

If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

Or if you prefer, call us at:

+34 946 42 41 42